1: (ROOT (S (S (NP (NNP Microsoft)) (VP (VBZ is) (VP (VBG teaming) (PRT (RP up)) (PP (IN with) (NP (NML (QP ($ a$) (CD 5) (CD billion))) (NNP Seattle) (NN biotech))) (S (VP (TO to) (VP (VB unravel) (NP (NP (DT the) (NN mystery)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (DT the) (JJ immune) (NN system)) (VP (VBZ responds) (PP (IN to) (NP (DT the) (NN coronavirus)))))))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD could) (VP (VB help) (PP (IN with) (NP (NP (NP (NN vaccine) (DT developmentThe) (NN range)) (PP (IN of) (NP (NP (NNS symptoms)) (CC and) (NP (NN disease) (NN severity)))) (PP (IN from) (NP (DT the) (JJ novel) (NN coronavirus)))) (VP (VBZ remains) (ADVP (RB largely)) (NP (NP (DT a) (NN mystery)) (PP (IN to) (NP (NNS doctors) (CC and) (NNS researchers)))))))))) (. .)))
2: (ROOT (S (NP (NNP Microsoft)) (VP (VBZ is) (VP (VBG working) (PP (IN with) (NP (DT the) (ADJP (NNP Seattl) (HYPH -) (VBN based)) (NN biotech) (NNP Adaptive) (NNPS Biotechnologies))) (S (VP (TO to) (ADVP (RB better)) (VP (VB understand) (NP (NP (DT the) (JJ different) (NNS ways)) (SBAR (WHADVP (IN that)) (S (NP (NP (NNS individuals) (POS ')) (JJ immune) (NNS systems)) (VP (VBP respond) (PP (IN to) (NP (DT the) (NN virus)))))))))))) (. .)))
3: (ROOT (S (NP (DT The) (NN duo)) (VP (VBP are) (ADVP (RB now)) (VP (VBG recruiting) (NP (QP (CD ,) (CD 000)) (NNS people)) (PP (IN for) (NP (NP (DT a) (NN study)) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB analyze) (NP (NP (NNP T) (NNS cells)) (, ,) (NP (NP (DT a) (JJ critical) (NN component)) (PP (IN in) (SBAR (WHADVP (WRB how)) (S (NP (JJ human) (NNS bodies)) (VP (VBP fight) (NP (VBG invading) (NNS threats)))))))))))))))) (. .)))
4: (ROOT (S (NP (DT The) (JJ early) (NN research)) (VP (MD could) (VP (VB help) (S (VP (VB build) (NP (NP (NN -cell) (NNS tests)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB supplement) (NP (NN antibody) (NN testing))))))))))) (. .)))
5: (ROOT (S (NP (PRP It)) (VP (MD could) (ADVP (RB also)) (ADVP (RB better)) (VP (VB instruct) (NP (NP (NNS vaccines) (CC and) (NNS therapeutics)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB now)) (PP (IN in) (NP (NN development))))))))) (. .)))
6: (ROOT (SINV (`` `) (S (SBAR (WHNP (WP What)) (S (NP (PRP we)) (VP (VBP 're) (VP (VBG developing))))) (VP (VBZ is) (NP (NP (NP (DT a) (JJ third) (NN pillar)) (PP (IN of) (NP (NNS diagnostics)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBG looking) (ADVP (RB specifically)) (PP (IN at) (NP (DT the) (NNP T) (NNS cells)))))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NNP Lance) (NNP Baldo)) (, ,) (NP (NP (JJ chief) (JJ medical) (NN officer)) (PP (IN of) (NP (NNP Adaptive) (NNPS Biotechnologies))))) (. .)))
7: (ROOT (S (VP (VB Visit) (NP (NP (NNP Business) (NNP Insider) (POS 's)) (NN homepage)) (PP (IN for) (NP (JJR more) (NNS stories)))) (. .)))
8: (ROOT (S (NP (DT The) (JJ novel) (NN coronavirus)) (VP (VBZ has) (VP (VBN confounded) (NP (NNS doctors)) (PP (IN by) (S (VP (VBG causing) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NNS symptoms)))) (PP (IN in) (NP (NNS patients)))))))) (. .)))
9: (ROOT (S (S (NP (CD COVI-19)) (VP (VBZ is) (ADVP (RB first) (CC and) (RB foremost)) (NP (DT a) (NN lung) (NN disease)))) (, ,) (CC but) (S (NP (PRP$ its) (NNS effects)) (VP (MD can) (VP (VB include) (NP (NP (NN blood) (NNS clots)) (, ,) (NP (NN heart) (NNS problems)) (, ,) (CC and) (NP (NP (RB even) (`` `) (NN COVID) (NNS toes) (POS ')) (SBAR (WHNP (WDT that)) (S (VP (VBP turn) (ADJP (JJ purple) (CC and) (JJ swollen)))))))))) (. .)))
10: (ROOT (S (S (NP (DT Some) (NNS patients)) (VP (VBP have) (NP (JJ mild) (NNS symptoms)))) (, ,) (CC and) (S (NP (NNS others)) (VP (VBP get) (ADJP (RB severely) (JJ ill)))) (. .)))
11: (ROOT (S (ADVP (RB Plus)) (, ,) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (RB critically) (JJ ill)) (NNS patients)))) (VP (VBP appear) (S (VP (TO to) (VP (VB suffer) (ADVP (ADVP (JJR more))) (PP (IN from) (NP (PRP$ their) (JJ own) (JJ immune) (NN response))) (PP (IN than) (PP (IN from) (NP (NP (DT the) (NN virus)) (NP (PRP itself))))))))) (. .)))
12: (ROOT (S (NP (DT The) (JJ immune) (NN system)) (VP (VBZ goes) (PP (IN into) (NP (NN hyperdrive))) (, ,) (S (VP (VP (VBG overreacting) (PP (IN to) (NP (DT the) (NN virus)))) (CC and) (VP (VBG causing) (NP (NP (JJ serious) (NN damage)) (PP (IN to) (NP (NP (DT the) (NN person) (POS 's)) (JJ own) (NN body)))))))) (. .)))
13: (ROOT (S (NP (NNS Researchers)) (VP (VBP are) (ADVP (RB now)) (VP (VBG trying) (S (VP (TO to) (VP (VB unravel) (NP (NP (DT the) (NNS mysteries)) (PP (IN about) (NP (NP (NP (DT the) (JJ immune) (NN system) (POS 's)) (NN response)) (PP (IN to) (NP (DT the) (NN coronavirus))))))))))) (. .)))
14: (ROOT (S (NP (NP (DT A) (JJR better) (NN understanding)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NNS humans)) (VP (VBP react) (PP (IN to) (NP (DT the) (NN virus)))))))) (VP (MD could) (VP (VB instruct) (NP (JJ future) (NNS diagnostics) (, ,) (NNS therapeutics) (, ,) (CC and) (NNS vaccines)))) (. .)))
15: (ROOT (S (NP (NP (DT The) (NN technology) (NN giant)) (NP (NNP Microsoft))) (VP (VBZ has) (VP (VBN jumped) (PP (IN into) (NP (DT this) (NN work))) (, ,) (S (VP (VBG focusing) (PP (IN on) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (NP (NP (DT the) (JJ immune) (NN response)) (VP (ADVP (RB not) (RB frequently)) (VBN talked) (PP (IN about)) (: -) (ADVP (ADVP (RB at) (RBS least)) (RB not) (RB yet)) (, -) (PP (IN with) (NP (CD COVI-19))))) (: :) (NP (NNP T) (NNS cells)))))))))) (. .)))
16: (ROOT (S (NP (NNP Microsoft)) (VP (VBZ is) (VP (VBG working) (PP (IN with) (NP (NP (NNP Adaptive) (NNPS Biotechnologies)) (, ,) (NP (NP (DT a) (NNP Seattle) (NN biotech)) (VP (VBG specializing) (PP (IN in) (S (VP (VBG decoding) (NP (JJ immune) (NNS responses))))))))))) (. .)))
17: (ROOT (S (NP (NNP Adaptive)) (VP (VBZ has) (NP (NP (DT a) (NN market) (NN value)) (PP (IN of) (NP (QP ($ about$) (CD .7) (CD billion)))))) (. .)))
18: (ROOT (S (NP (DT The) (NN duo)) (VP (VBP are) (VP (VBG hoping) (SBAR (IN that) (S (NP (NP (JJR better) (VBG understanding) (NP (DT the) (NN -cell) (NN response))) (PP (IN in) (NP (NNS humans)))) (VP (MD could) (VP (VB be) (VP (VB help) (S (VP (VB understand) (CC and) (VB fight) (NP (DT the) (NN virus))))))))))) (. .)))
19: (ROOT (S (NP (NNP Microsoft)) (VP (MD will) (VP (VB help) (S (VP (VB crunch) (NP (NP (DT the) (JJ massive) (NN amount)) (PP (IN of) (NP (VBN collected) (NNS data)))) (S (VP (VBG using) (NP (PRP$ its) (NML (NML (NML (NN machine) (NN learning)) (NNS capabilities)) (CC and) (NML (NNP Azure) (NN cloud) (NN platform)))))))))) (. .)))
20: (ROOT (S (NP (DT The) (CD two)) (VP (VBD started) (S (VP (VBG working) (ADVP (RB together)) (PP (IN in) (NP (CD 2018))) (S (VP (TO to) (VP (VB develop) (NP (NP (DT a) (NN -cell) (NN blood) (NN test)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB detect) (NP (NP (JJ multiple) (NNS diseases)) (, ,) (PP (JJ such) (IN as) (NP (NNP Lyme) (NN disease))))))))))))))) (. .)))
21: (ROOT (S (SBAR (IN While) (S (NP (DT that) (NN work)) (VP (VBZ is) (ADJP (JJ ongoing))))) (, ,) (NP (DT the) (NNS companies)) (VP (VBD expanded) (NP (DT the) (NN agreement)) (PP (IN in) (NP (NNP March))) (S (VP (TO to) (VP (VB include) (NP (CD COVI-19)))))) (. .)))
22: (ROOT (S (NP (NNS Antibodies)) (VP (VP (VBP have) (VP (VBN been) (NP (NP (DT a) (NN research) (NN focus)) (PP (IN for) (NP (NP (CD COVI-19) (NN testing)) (, ,) (NP (NNS therapeutics)) (, ,) (CC and) (NP (NNS vaccines))))))) (NP (NNS Antibodies)) (VP (VBP have) (VP (VBN been) (NP (NP (DT the) (NN star)) (PP (IN of) (NP (DT the) (NN show)))) (, ,) (S (VP (VBG hogging) (NP (NP (JJ much)) (PP (IN of) (NP (DT the) (JJ early) (NN attention))))))))) (. .)))
23: (ROOT (S (NP (DT These) (ADJP (NN viru) (HYPH -) (VBG fighting)) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN known) (PP (IN by) (NP (NNS scientists))) (PP (IN for) (NP (QP (NP (JJR more)) (IN than) (DT a)) (NN century)))))) (. .)))
24: (ROOT (S (S (VP (VBG Going) (ADVP (RB back)) (PP (IN to) (NP (DT the) (CD 1918) (NN influenza) (NN pandemic))))) (, ,) (NP (PRP they)) (VP (VBP are) (NP (NP (NP (DT the) (JJ key) (NN ingredient)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (VP (VBN called) (S (NP (JJ convalescent) (NN plasma))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ helps) (S (NP (DT the) (JJ sick)) (VP (VB recover)))))))) (. .)))
25: (ROOT (S (PP (IN Over) (NP (DT the) (JJ last) (CD three) (NNS decades))) (, ,) (NP (NNS scientists)) (VP (VBP have) (VP (VBN developed) (NP (NP (NNS methods)) (SBAR (S (VP (TO to) (VP (VP (VB screen) (NP (NNS antibodies)) (PP (IN for) (NP (NN potency)))) (, ,) (ADVP (RB then)) (VP (VB clone) (CC and) (VB produce) (NP (DT the) (JJS best) (NNS candidates)) (PP (IN at) (NP (JJ massive) (NN scale))))))))))) (. .)))
26: (ROOT (S (NP (DT These) (NN antibody) (NNS treatments)) (VP (VBP are) (ADVP (RB now)) (VP (VBG being) (VP (VBN developed) (PP (IN for) (NP (CD COVI-19))) (, ,) (SBAR (IN with) (S (NP (JJ human) (NN testing)) (VP (VBN expected) (S (VP (TO to) (VP (VB start) (NP (DT this) (NN summer))))))))))) (. .)))
27: (ROOT (S (NP (NNS Antibodies)) (VP (VBP have) (ADVP (RB also)) (VP (VBN become) (NP (NP (DT a) (NN focus)) (PP (IN of) (NP (DT the) (JJ diagnostic) (NN world)))))) (. .)))
28: (ROOT (S (S (VP (VBN Called) (S (NP (JJ serological) (NNS tests))))) (, ,) (NP (DT a) (NN blood) (NN sample)) (VP (MD can) (VP (VB reveal) (SBAR (IN if) (S (NP (NN someone)) (VP (VBZ has) (NP (ADJP (NN coronaviru) (HYPH -) (VBG fighting)) (NNS antibodies))))))) (. .)))
29: (ROOT (S (SBAR (IN If) (S (NP (PRP they)) (VP (VBP do)))) (, ,) (NP (PRP it)) (ADVP (RB likely)) (VP (VBZ suggests) (NP (NP (DT a) (NN level)) (PP (IN of) (NP (NP (NN protection)) (PP (IN against) (NP (NN r) (HYPH -) (NN infection))))))) (. .)))
30: (ROOT (S (NP (DT The) (JJS best) (JJ serological) (NNS tests)) (ADVP (RB now)) (VP (VBP have) (NP (ADJP (RB extremely) (JJ high)) (NN accuracy) (NNS rates))) (. .)))
31: (ROOT (S (NP (NNS Antibodies)) (VP (MD will) (ADVP (RB also)) (ADVP (RB likely)) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN race)) (PP (IN for) (NP (DT a) (NN coronavirus) (NN vaccine))))))) (. .)))
32: (ROOT (S (NP (NNS Researchers)) (VP (VBP are) (ADVP (RB now)) (VP (VBG trying) (S (VP (TO to) (VP (VB figure) (PRT (RP out)) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NNS antibodies)) (VP (VBN needed) (PP (IN in) (NP (DT the) (NN body))) (S (VP (TO to) (VP (VB protect) (PP (IN against) (NP (NN infection))))))))))))))) (. .)))
33: (ROOT (S (NP (DT That)) (VP (MD could) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (DT an) (JJ indirect) (NN measure))) (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (JJ experimental) (NNS vaccines)) (VP (VBP are) (VP (VBG producing) (NP (JJ enough) (NNS antibodies) (S (VP (TO to) (VP (VB protect) (NP (NNS people)))))))))))))))) (. .)))
34: (ROOT (S (S (NP (NNP T) (NNS cells)) (VP (MD could) (ADVP (RB also)) (VP (VB play) (NP (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (CD COVI-19))))))) (CC But) (S (NP (NNS antibodies)) (VP (VBP are) (NP (NP (QP (RB just) (CD one)) (NN part)) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))))) (. .)))
35: (ROOT (S (NP (NP (DT Another) (JJ key) (NN element)) (PP (IN in) (S (VP (VBG fighting) (NP (JJ viral) (NNS infections)))))) (VP (VBZ is) (NP (NNP T) (NNS cells))) (. .)))
36: (ROOT (S (NP (NNP T) (NNS cells)) (VP (VBP are) (NP (NP (NP (DT the) (NN body) (POS 's)) (JJ first) (NN response)) (PP (IN to) (NP (NP (DT a) (JJ foreign) (NN invader)) (PP (IN in) (NP (DT the) (NN body))))))) (. .)))
37: (ROOT (S (S (NP (DT Some) (NNP T) (NNS cells)) (VP (MD will) (VP (VP (VB kill) (NP (JJ infected) (NNS cells))) (CC and) (VP (VB fight) (NP (DT the) (NN virus)))))) (, ,) (CC and) (S (NP (NNS others)) (VP (VP (VBP help) (VP (VB pump) (PRT (RP out)) (NP (NNS antibodies)))) (CC and) (VP (VB coordinate) (NP (NP (DT the) (NN body) (POS 's)) (NN attack))))) (. .)))
38: (ROOT (S (SBAR (IN While) (S (NP (NP (JJ much)) (PP (IN of) (NP (HYPH COVI-19) (NN research)))) (VP (VBZ is) (VP (VBG digging) (PP (IN into) (NP (DT the) (NN antibody) (NN response))))))) (, ,) (NP (DT the) (NN -cell) (NN response)) (VP (VBZ remains) (NP (NP (JJR more)) (PP (IN of) (NP (DT a) (NN mystery))))) (. .)))
39: (ROOT (S (S (VP (TO To) (ADVP (RBR better)) (VP (VB understand) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP T) (NNS cells))))))) (, ,) (NP (NNP Microsoft) (CC and) (NNP Adaptive)) (VP (VBP have) (VP (VBN launched) (NP (DT a) (NML (-LRB- ,) (NML (CD 00) (HYPH -) (NN person))) (NN study)) (PP (IN across) (NP (DT the) (NNP US))))) (. .)))
40: (ROOT (S (NP (DT The) (NN research)) (VP (VP (VBZ is) (ADJP (JJ early))) (, ,) (CC and) (VP (VBZ plans) (S (VP (TO to) (VP (VB explore) (SBAR (WHADVP (WRB how)) (S (NP (NN -cell) (NNS responses)) (VP (VBP vary) (PP (PP (IN from) (NP (NN person))) (PP (IN to) (NP (NN person)))))))))))) (. .)))
41: (ROOT (S (NP (PRP They)) (VP (VBP are) (VP (VBG recruiting) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VP (VBP have) (ADVP (RB likely)) (VP (VBN been) (VP (VBN exposed) (PP (IN to) (NP (DT the) (NN virus)))))) (, ,) (VP (VBP are) (ADJP (VBN infected))) (, ,) (CC and) (VP (VBP have) (ADVP (RB recently)) (VP (VBN recovered))))))))) (. .)))
42: (ROOT (S (NP (NNS Volunteers)) (VP (MD will) (VP (VB have) (S (S (NP (PRP$ their) (NN blood)) (VP (VBN drawn))) (CC and) (S (S (NP (NN nose) (CC or) (NN throat)) (VBN swabbed)) (PP (IN by) (NP (NP (DT a) (NN phlebotomist)) (SBAR (WHNP (WP who)) (S (VP (MD will) (VP (VB visit) (NP (PRP$ their) (NN home)))))))))))) (. .)))
43: (ROOT (S (NP (NP (NNP Lance) (NNP Baldo)) (, ,) (NP (NP (DT the) (JJ chief) (JJ medical) (NN officer)) (PP (IN of) (NP (NNP Adaptive)))) (, ,)) (VP (VBD said) (SBAR (S (NP (PRP he)) (VP (VBZ hopes) (SBAR (S (NP (DT the) (NNS findings)) (VP (MD could) (VP (VB help) (S (VP (VB build) (NP (NP (JJR better) (NNS diagnostics) (, ,) (NNS therapeutics) (, ,) (CC and) (NNS vaccines)) (PP (IN for) (NP (HYPH COVI-19)))))))))))))) (. .)))
44: (ROOT (S (S (-LRB- `) (S (VP (VBG Developing) (NP (NP (DT a) (JJ third) (NN pillar)) (PP (IN of) (NP (NNS diagnostics)))))) (POS ') ('' `) (S (SBAR (WHNP (WP What)) (S (NP (PRP we)) (VP (VBP 're) (VP (VBG developing))))) (VP (VBZ is) (NP (NP (NP (DT a) (JJ third) (NN pillar)) (PP (IN of) (NP (NNS diagnostics)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBG looking) (ADVP (RB specifically)) (PP (IN at) (NP (DT the) (NNP T) (NNS cells))))))))))) (, ,) ('' ') (NP (NNP Baldo)) (VP (VBD said) (PP (IN in) (NP (DT an) (NN interview)))) (. .)))
45: (ROOT (S (NP (DT A) (NN -cell) (NN test)) (VP (MD could) (VP (VB complement) (NP (JJ serological) (NN testing)) (, ,) (SBAR (ADVP (RB particularly)) (IN if) (S (NP (PRP it)) (VP (MD can) (VP (VB help) (S (VP (VB identify) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (NNS gaps)) (PP (IN in) (NP (ADJP (RB antibod) (HYPH -) (VBN based)) (NNS tests)))))))))))))) (. .)))
46: (ROOT (S (NP (NP (PRP It))) (VP (VBZ 's) (ADJP (JJ unclear)) (SBAR (IN if) (S (NP (DT every) (VBN recovered) (HYPH COVI-19) (NN patient)) (VP (VBZ generates) (NP (ADJP (NN lon) (HYPH -) (JJ lasting)) (, ,) (JJ protective) (NNS antibodies)))))) (. .)))
47: (ROOT (S (S (SBAR (IN If) (S (NP (DT some)) (VP (VBP do) (RB not) (VP (VB develop) (NP (DT a) (JJ meaningful) (NN antibody) (NN response)))))) (, ,) (NP (DT a) (NN -cell) (NN test)) (VP (MD could) (VP (VB help) (S (VP (VB figure) (PRT (RP out)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADVP (RB truly)) (VP (VBN protected)))))))))) (, ,) (NP (NNP Baldo)) (VP (VBD said)) (. .)))
48: (ROOT (S (NP (NNP T) (NNS cells)) (VP (VBP have) (ADVP (RB mainly)) (VP (VBN been) (NP (NP (DT the) (NN focus)) (PP (IN of) (NP (NP (NN cancer) (NNS treatments)) (, ,) (ADJP (ADVP (RB perhaps) (RBS best)) (VBN known) (PP (IN for) (NP (NP (DT the) (NML (NN CA) (HYPH -) (NNP T)) (NNS therapies)) (SBAR (WHNP (WDT that)) (S (ADVP (RB first)) (VP (VBD came) (PP (IN to) (NP (NN market))) (PP (IN in) (NP (CD 2017)))))))))))))) (. .)))
49: (ROOT (S (NP (DT These) (ADJP (NN groun) (HYPH -) (JJ breaking)) (NNS treatments)) (VP (VBP fight) (NP (NP (JJ certain) (NNS types)) (PP (IN of) (NP (NN cancer)))) (S (VP (VBG using) (NP (NP (NNS patients) (POS ')) (JJ own) (NNP T) (NNS cells)))) (, ,) (S (ADVP (RB genetically)) (VP (VBG engineering) (NP (PRP them)) (S (VP (TO to) (VP (VB be) (ADJP (RBR more) (JJ potent)))))))) (. .)))
50: (ROOT (S (NP (PRP It)) (VP (VBZ 's) (ADJP (RB too) (JJ early) (S (VP (TO to) (VP (VB know) (SBAR (IN if) (S (NP (EX there)) (VP (MD could) (VP (VB be) (NP (NP (DT a) (JJ similar) (NN treatment)) (PP (IN for) (NP (CD COVI-19))))))))))))) (. .)))
51: (ROOT (S (NP (NML (NNP CA) (HYPH -) (NNP T)) (NNS therapies)) (VP (VBP are) (ADJP (JJ complicated) (CC and) (JJ expensive)) (, ,) (PP (IN with) (NP (JJ serious) (JJ potential) (JJ side) (NNS effects)))) (. .)))
52: (ROOT (S (CC But) (NP (DT the) (NN -cell) (NN trial)) (VP (MD could) (VP (VB help) (S (VP (VB answer) (NP (NP (JJ many) (NNS questions)) (PP (IN about) (NP (DT the) (NN coronavirus)))))))) (. .)))
53: (ROOT (S (NP (NNP Baldo)) (VP (VBD said) (SBAR (S (NP (PRP$ his) (NNS researchers)) (VP (VBP are) (VP (VBG planning) (S (VP (TO to) (VP (VB use) (NP (DT the) (NNS data)) (S (VP (TO to) (VP (VB map) (NP (NP (DT the) (JJ natural) (NN decay)) (PP (IN of) (NP (NNP T) (NNS cells))))))))))))))) (. .)))
54: (ROOT (S (NP (DT This)) (VP (MD could) (VP (VB help) (S (VP (VB quantify) (SBAR (WHADVP (WRB when)) (S (NP (NN someone)) (VP (VBD was) (ADVP (RB first)) (VP (VBN infected) (PP (IN with) (NP (CD COVI-19))))))))))) (. .)))
55: (ROOT (S (NP (DT Another) (JJ potential) (NN use)) (VP (MD would) (VP (VB be) (S (VP (VBG flagging) (NP (NP (NNS people)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB suffer) (PP (IN from) (NP (NP (DT an) (JJ overactive) (JJ immune) (NN response)) (PP (IN to) (NP (NN infection))))))))))))))))) (. .)))
56: (ROOT (S (NP (DT The) (NN research)) (VP (MD could) (VP (VB help) (S (VP (VB explain) (SBAR (WHADVP (WRB why)) (S (NP (DT some) (JJ infected) (NNS people)) (VP (VBP have) (NP (JJ mild) (NNS symptoms)) (SBAR (IN while) (S (NP (NNS others)) (VP (VBP wind) (PRT (RP up)) (PP (IN on) (NP (NNS ventilators))))))))))))) (. .)))
57: (ROOT (S (S (NP (NNP ICU) (NNS patients)) (VP (VBP have) (NP (NP (ADJP (RB significantly) (JJR lower)) (NNS levels)) (PP (IN of) (NP (NNS -cells))) (PP (IN than) (NP (JJ other) (NNS patients)))))) (, ,) (NP (DT some) (JJ early) (NNS findings)) (VP (VBP suggest)) (. .)))
58: (ROOT (S (NP (DT A) (NN -cell) (NN test)) (VP (MD could) (VP (VB add) (NP (DT an) (JJ extra) (NN stamp)) (PP (IN on) (NP (NP (NP (DT the) (NN immunity) (NN passport)) (NP (NP (NNS Policymakers)) (PP (IN across) (NP (DT the) (NN world))))) (VP (VBP are) (VP (VBG mulling) (NP (NP (DT the) (NN idea)) (PP (IN of) (`` `) (NP (NN immunity) (NNS passports)))))))))) (. .) ('' ')))
59: (ROOT (S (NP (DT The) (NN idea)) (VP (VBG being) (SBAR (IN that) (S (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN recovered) (PP (IN from) (NP (DT the) (NN virus)))))))) (VP (VP (VBP are) (ADJP (JJ likely) (S (ADJP (JJ immune) (PP (IN to) (NP (FW r) (HYPH -) (NN infection))))))) (, ,) (CC and) (VP (MD could) (ADVP (RB safely)) (VP (VB r) (HYPH -) (VP (VB enter) (NP (DT the) (NN workforce) (CC and) (NN society))))))))) (. .)))
60: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (ADJP (JJ ethical) (CC and) (JJ scientific)) (NNS concerns)) (PP (IN around) (NP (DT the) (NN idea)))) (. .)))
61: (ROOT (S (NP (PRP We)) (VP (VBP do) (RB not) (VP (VB know) (SBAR (WHADJP (WHADJP (WRB how) (RB lon) (HYPH -) (VBG lasting)) (NP (NP (DT any) (NN type)) (PP (IN of) (NP (NN immunity))))) (VP (VBZ is))))) (. .)))
62: (ROOT (S (CC And) (NP (PRP it)) (VP (MD could) (VP (VB incentivize) (NP (NNS people)) (S (VP (TO to) (ADVP (RB intentionally)) (VP (VB try) (S (VP (TO to) (VP (VB get) (VP (VBN infected)))))))) (, ,) (SBAR (IN if) (S (NP (DT the) (NN alternative)) (VP (VBZ is) (VP (VBG sheltering) (ADVP (RB inside)) (SBAR (IN while) (S (NP (NNS others)) (VP (VBP are) (ADJP (JJ free) (S (VP (TO to) (VP (VB roam)))))))))))))) (. .)))
63: (ROOT (S (`` `) (S (NP (NN Immunity)) (VP (VBZ is) (VP (VBG going) (S (VP (TO to) (VP (VB be) (ADJP (JJ hard)) (, ,) (SBAR (IN because) (S (PP (IN for) (NP (NN immunity))) (NP (PRP you)) (ADVP (RB really)) (VP (VBP need) (NP (NN r) (HYPH -) (NN exposure)) (SBAR (IN if) (S (NP (PRP you)) (VP (VBP 're) (VP (VBG going) (S (VP (TO to) (VP (VB say) (SBAR (IN that) (S (NP (PRP you)) (VP (VBP are) (ADJP (JJ immune))))))))))))))))))))) (, ,) ('' ') (NP (NNP Baldo)) (VP (VBD said)) (. .) ('' ')))
64: (ROOT (S (S (NP (PRP We)) (VP (MD can) (VP (VB impute) (SBAR (IN that) (S (NP (NN someone)) (VP (VBZ is) (ADJP (JJ immune)))))))) (, ,) (CC but) (S (S (VP (TO to) (ADVP (RB actually)) (VP (VB say) (SBAR (S (NP (NN someone)) (VP (VBZ is) (ADJP (JJ immune)))))))) (VP (VBZ is) (VP (VBG going) (S (VP (TO to) (VP (VB be) (ADJP (JJ hard)) (PP (IN for) (NP (DT a) (NN while))))))))) (. .) ('' ')))
65: (ROOT (S (NP (NNP Baldo)) (VP (VP (VBZ has) (NP (NP (NNS reservations)) (PP (IN about) (NP (DT the) (NML (NN immunity) (NN passport)) (NN concept))))) (, ,) (CC but) (VP (VBD added) (SBAR (S (SBAR (IN if) (S (NP (NNS countries)) (VP (VBP do) (VP (VB take) (NP (DT that) (NN approach)))))) (NP (PRP it)) (ADVP (RB likely)) (VP (VBP wo) (VP (`` ') (RB t) (VP (VB be) (NP (QP (RB just) (CD one)) (NN test))))))))) (. .)))
66: (ROOT (S (ADVP (RB Instead)) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB require) (NP (NP (JJ several) (NN serology) (NNS tests)) (ADVP (IN along) (PP (IN with) (NP (NP (DT a) (NN -cell) (NN test)) (, ,) (PP (IN for) (NP (NN instance))) (, ,) (PP (IN like) (S (VP (VBG collecting) (NP (JJ multiple) (NNS stamps)) (PP (IN on) (NP (DT a) (NN passport)))))))))))) (. .)))
67: (ROOT (S (NP (NP (NNP Adaptive) (POS 's)) (NNP Baldo)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBP are) (VP (VBG hoping) (S (VP (TO to) (VP (VB draw) (NP (DT some) (JJ initial) (NNS insights)) (PP (IN from) (NP (DT this) (NN -cell) (NN study))) (PP (IN in) (NP (NNP June))))))))))) (. .)))
68: (ROOT (S (NP (DT The) (NNS companies)) (VP (VBP have) (VP (VBN pledged) (S (VP (TO to) (VP (VB make) (S (NP (DT the) (NNS data)) (ADJP (RB freely) (JJ available) (PP (IN to) (NP (NNS researchers)))))))))) (. .)))
69: (ROOT (S (ADVP (RB So) (RB far)) (, ,) (S (NP (QP (RB about) (CD 100)) (NNS people)) (VP (VBP have) (VP (VBN joined)))) (CC and) (S (NP (DT the) (NN study)) (VP (VBZ is) (VP (VBG recruiting) (PP (IN in) (NP (NP (QP (RB roughly) (CD two) (CD dozen)) (NN metro) (NNS areas)) (PP (IN across) (NP (DT the) (NNP US)))))))) (. .)))
70: (ROOT (S (NP (NP (JJR More) (NN information)) (PP (IN on) (S (VP (VBG signing) (PRT (RP up)))))) (VP (VBZ is) (ADJP (JJ available)) (PP (IN at) (NP (PRP immunerac.com)))) (. .)))
